Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Health Catalyst, Inc. HCAT

Healthcare  —  Health Information Services
1.74 0.00 0.00% as of 25 Sep
Market cap
$131.0M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

 (31.33%) (58.26%) (103.02%) (118.12%)
ROA (15.37%) (26.14%) (40.69%) (54.33%)
ROIC (14.66%) (33.15%) (84.56%) (102.14%)
Return on Tangible Assets (97.78%) (156.71%) (241.95%) (139.42%)
Average Days of Receivables 69.42 69.36 71.37 52.33
Free Cash Flow per Share (0.48) (0.30) (0.04) 0.09
Free Cash Flow (33.46) (20.78) (2.71) 6.59
Capital Expenditures (20.76) (21.51) (21.68) (21.65)
Piotroski F-Score 5.00 6.00 6.00 5.00
Other line items
Cash ROIC (2.20%) 0.15% 4.74% 7.89%
Accounts Receivable Turnover 5.66 5.35 4.91 5.30
Accounts Payable Turnover 17.59 15.34 14.69 16.75
Inventory Turnover 0.00 0.00 0.00 0.00
Average Days of Payables 10.67 21.43 28.16 21.03
Days of Inventory on Hand 0.00 0.00 0.00 0.00
Tax Rate 0.01 0.00 0.00 0.00
Research and Development Expense of Revenue 17.36% 16.00% 14.67% 14.71%
Selling, General and Administrative Expense of Revenue 34.09% 32.79% 32.29% 33.70%
Share Based Compensation of Revenue 10.67% 8.68% 7.68% 6.03%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income 0.12 0.00 (0.07) (0.11)
Depreciation/Fixed assets 2.48 4.86 7.42 7.63
Capex/Depreciation (0.26) (0.13) (0.08) (0.08)
Revenue per Share 4.49 4.45 4.17 3.95
Operating CF per Share (0.18) 0.01 0.26 0.38
Capex per Share (0.29) (0.31) (0.30) (0.29)
Capex to Sales 0.07 0.07 0.07 0.07
Net Profit Margin (34.05%) (57.20%) (87.69%) (90.61%)

Fold the line items

Columns are period end dates